OncLive SOSS

Patient Profiles in HER2-Positive Breast Cancer - Episode 14

Patient Profile 2: Strategies for Managing Brain Metastases in HER2+ Metastatic Breast Cancer

May 26, 2022

Shanu Modi, MD, Rena D. Callahan, MD, Tiffany A. Traina, MD, Sara M. Tolaney, MD, MPH

Shared insight on strategies for managing brain metastases in patients with HER2+ breast cancer.

EP. 1: HER2+ Breast Cancer: Overview of the Treatment Armamentarium

EP. 2: Selecting and Sequencing Therapy for HER2+ Breast Cancer

EP. 3: Recent Trial Data in HER2+ Metastatic Breast Cancer

EP. 4: Patient Profile 1: Frontline Therapy for HER2+ mBC

EP. 5: Patient Profile 1: Second-Line Therapy for HER2+ mBC

EP. 6: Patient Profile 1: Sequencing Therapies in HER2+ mBC

EP. 7: Patient Profile 2: Patient with Triple-Positive mBC

EP. 8: Patient Profile 2: Second-Line Therapy for Triple-Positive mBC

EP. 9: Patient Profile 2: 3L Therapy for Triple-Positive mBC

EP. 10: Considering Novel Therapy for HER2+ Metastatic Breast Cancer

EP. 11: Patient Profile 1: 62-Year-Old Woman With Metastatic Breast Cancer

EP. 12: Patient Profile 1: Trastuzumab Deruxtecan for HER2+ Metastatic BC

EP. 13: Patient Profile 2: 26-Year-Old Woman With Triple Positive Breast Cancer

EP. 14: Patient Profile 2: Strategies for Managing Brain Metastases in HER2+ Metastatic Breast Cancer

EP. 15: Patient Profile 2: How Should T-DM1 Be Sequenced in HER2+ mBC?

EP. 16: Patient Profile 2: Clinical Utility of the HER2CLIMB Regimen for HER2+ mBC

EP. 17: Patient Profile 2: Treatment Sequencing in a Patient with Progressive Brain Metastases

EP. 18: Patient Profile 3: 43-Year-Old Woman With Metastatic Breast Cancer Progressing Through Multiple Lines of Therapy

EP. 19: Patient Profile 3: Treatment Sequencing in a Patient with metastatic HER2+ Breast Cancer

EP. 20: Patient Profile 4: Strategies for Managing ILD in Patients Receiving Trastuzumab Deruxtecan

EP. 21: Patient Profile 4: Managing AEs in Patients Receiving Treatment for HER2+ BC

EP. 22: Patient Profile 5: Strategies for Managing Elevated Liver Function Tests in Patients on the HER2CLIMB Regimen

EP. 23: Future Directions in the Management of HER2+ Breast Cancer